Amesite Inc. (AMST)
NASDAQ: AMST · Real-Time Price · USD
3.350
+0.150 (4.69%)
At close: Jan 17, 2025, 4:00 PM
3.190
-0.160 (-4.78%)
After-hours: Jan 17, 2025, 4:10 PM EST

Company Description

Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States.

Its products include Amesite Engage that enables colleges and universities to offer courses and programs that build professional skills; and NurseMagic, a healthcare app that specifically targets the segments in healthcare, including nurses and caregivers offering support to do jobs, manage stress, complete documentation, and perform other tasks.

It serves enterprises, universities, and K-12 schools. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.

Amesite Inc.
Amesite logo
Country United States
Founded 2017
IPO Date Sep 25, 2020
Industry Software - Application
Sector Technology
Employees 9
CEO Ann Sastry

Contact Details

Address:
607 Shelby Street, Suite 700
Detroit, Michigan 48226
United States
Phone 734 876 8130
Website amesite.com

Stock Details

Ticker Symbol AMST
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
IPO Price $5.00
CIK Code 0001807166
CUSIP Number 031094105
ISIN Number US0310942042
Employer ID 82-3431717
SIC Code 7372

Key Executives

Name Position
Dr. Ann Marie Sastry Ph.D. Chairperson, President and Chief Executive Officer
Sherlyn W. Farrell Chief Financial Officer
Brandon Owens Vice President of Sales
Kalie Wortinger Senior Manager of Engineering
Jay Majumdar Vice President of Partnerships

Latest SEC Filings

Date Type Title
Jan 10, 2025 8-K Current Report
Jan 7, 2025 424B5 Filing
Jan 6, 2025 424B5 Filing
Jan 2, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jan 2, 2025 10-Q/A [Amend] Quarterly report
Jan 2, 2025 10-K/A [Amend] Annual report
Dec 23, 2024 S-8 Securities to be offered to employees in employee benefit plans
Dec 23, 2024 8-K Current Report
Dec 23, 2024 8-K Current Report
Dec 18, 2024 EFFECT Notice of Effectiveness